Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

• Status: Completed
• Trial end date: 2016-08-09

Summary

This study will evaluate the safety and efficacy of new ophthalmic formulations of bimatoprost in patients with open angle glaucoma and ocular hypertension. At least 3 dose strengths will be evaluated based on internal data review of each cohort. The study was planned to be conducted in 2 stages. Stage 1 was an open-label and Stage 2 was planned to be masked; however only Stage 1 was conducted.

• Phase: Phase 1/Phase 2

Details

• Lead Sponsor: Allergan
• Treatments: Bimatoprost; Latanoprost; Ophthalmic Solutions; Pharmaceutical Solutions; Timolol